StonvexLoading…
StonvexStonvexStonvexCore line items from CSX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $3.48B | $14.09B | $10.58B | $7.00B |
Operating Income | $1.25B | $4.52B | $3.41B | $2.32B |
Net Income | $807.00M | $2.89B | $2.17B | $829.00M |
EPS (Diluted) | $0.43 | $1.54 | $1.16 | $0.78 |
Total Assets | $44.23B | $43.68B | $43.28B | $42.93B |
Total Liabilities | $30.65B | $30.52B | $30.52B | $30.55B |
Cash & Equivalents | $964.00M | $670.00M | $612.00M | $387.00M |
Free Cash Flow OCF − CapEx | $729.00M | $1.71B | $1.00B | $395.00M |
Shares Outstanding | 1.86B | 1.86B | 1.88B | 1.88B |